Specific Adverse Events Predict Survival Benefit in Early Breast Cancer Patients Treated with Exemestane in the Dutch/Belgian TEAM Trial

Author(s):
Fontein, D.; Houtsma, D.; Hille, E.T.M.; Kranenbarg, W.M.M.K.; Putter, H.; Seynaeve, C.; Dirix, L.Y.; Paridaens, R.; Velde, C.J.H. van de (0000-0003-0104-1800); Nortier, J.W.R.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-03-31
Language
English
Is part of
European Journal of Cancer (2012), Vol. 48, p. S101-S101
hdl
1887/97999
doi
10.1016/S0959-8049(12)70266-6